Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Harvard Business School
Moodys
Colorcon
Mallinckrodt

Last Updated: September 25, 2022

ZOSYN IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Zosyn In Plastic Container patents expire, and what generic alternatives are available?

Zosyn In Plastic Container is a drug marketed by Wyeth Pharms and is included in one NDA. There are three patents protecting this drug.

This drug has forty-one patent family members in thirty-four countries.

The generic ingredient in ZOSYN IN PLASTIC CONTAINER is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.

DrugPatentWatch® Generic Entry Outlook for Zosyn In Plastic Container

Indicators of Generic Entry

< Available with Subscription >

  Try it Free

US Patents and Regulatory Information for ZOSYN IN PLASTIC CONTAINER

ZOSYN IN PLASTIC CONTAINER is protected by three US patents.

Patents protecting ZOSYN IN PLASTIC CONTAINER

Compositions containing pipercillin and tazobactam useful for injection
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATING BACTERIAL INFECTIONS

Compositions containing piperacillin and tazobactam useful for injection
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Compositions containing piperacillin and tazobactam useful for injection
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATING BACTERIAL INFECTIONS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-003 Feb 24, 1998 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-002 Feb 24, 1998 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZOSYN IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-003 Feb 24, 1998 See Plans and Pricing See Plans and Pricing
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 See Plans and Pricing See Plans and Pricing
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-002 Feb 24, 1998 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ZOSYN IN PLASTIC CONTAINER

See the table below for patents covering ZOSYN IN PLASTIC CONTAINER around the world.

Country Patent Number Title Estimated Expiration
Russian Federation 2322980 КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПИПЕРАЦИЛЛИН И ТАЗОБАКТАМ,ПРИМЕНИМЫЕ ДЛЯ ИНЪЕКЦИИ (PIPERACILLIN AND TAZOBACTAM-CONTAINING COMPOSITIONS USED FOR INJECTION) See Plans and Pricing
Canada 2464258 COMPOSITIONS RENFERMANT DE LA PIPERACILLINE ET DU TAZOBACTAMUTILES EN INJECTION (COMPOSITIONS CONTAINING PIPERACILLIN AND TAZOBACTAM USEFUL FOR INJECTION) See Plans and Pricing
New Zealand 543005 Compositions containing piperacillin and tazobactam useful for injection See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
McKesson
Harvard Business School
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.